Clinical Trials
The Center for Research on Women’s Health and Reproductive Medicine is currently conducting the following clinical research studies in reproductive medicine:
Fragile X Premutations Among Women With Infertility
The purpose of this research study is to see how common the Fragile X (FMR1) premutation is in women with a particular infertility-related ovarian condition called “diminished ovarian reserve”. Genes contain instructions that tell our bodies how to develop and function properly. The blood test used in this study will look for a specific genetic abnormality (called “fragile X or FMR1 premutation”) that may indicate an increased chance for developing premature depletion of eggs, early menopause and, infertility. Stanford University and the University of Virginia are collaborating on this study. Enrolled participants will receive a $50 gift card and free genetic testing. Those participants who wish to learn the results of their genetic testing will also receive genetic counseling free of charge. See details.
For more information, please contact:
Rebecca A. Briggs
Clinical Trials Research Coordinator
rabriggs@stanford.edu
(650) 723-9514
A Study for the Evaluation of Stress Reduction Techniques During In-Vitro Fertilization
The purpose of this research study is to examine the effect of healing touch therapy to reduce stress in women currently undergoing IVF. If you are under the age of 43, undergoing an IVF cycle at the Stanford Fertility and Reproductive Medicine Center, and not currently seeking other energy work (reiki, acupuncture, massage, etc.) then you may be eligible for this study. Women will be randomized to one of three treatment groups: either 3 Healing Touch sessions, or 3 De-sensitization Therapy sessions or no intervention (control group). See details.
For more information, please contact:
Kathy Turner, RN, NP
Clinical Trials Research Coordinator
kathyt@stanford.edu
(650) 724-6850
